High-intensity focused ultrasound ablation combined with transcatheter arterial chemoembolization improves long-term efficacy and prognosis of primary liver cancer

Background: To investigate the clinical efficacy of high-intensity focused ultrasound (HIFU) combined with transcatheter arterial chemoembolization (TACE) in the treatment of primary liver cancer (PLC) and its effect on the prognosis of patients. Methods: A total of 132 patients with PLC admitted to...

Full description

Bibliographic Details
Main Authors:	Bai, J. (Author), Li, M. (Author), Li, S. (Author), Shang, P. (Author), Sun, M. (Author)
Format:	Article
Language:	English
Published:	John Wiley and Sons Inc 2021
Subjects:	adult Adult adverse event Antigens, CD Article blood burn cancer patient cancer prognosis cancer survival cancer therapy CD3 antigen CD4 antigen CD8 antigen chemoembolization Chemoembolization, Therapeutic clinical effectiveness controlled clinical trial controlled study efficacy female Female high intensity focused ultrasound High-Intensity Focused Ultrasound Ablation hospital admission human Humans Killer Cells, Natural leukocyte antigen liver cancer liver failure Liver Neoplasms liver tumor long term care loss of appetite major clinical study male Male middle aged Middle Aged mortality natural killer cell nausea primary liver cancer procedures prognosis Prognosis survival rate Survival Rate TACE combined with HIFU regimen treatment outcome Treatment Outcome treatment planning
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

High-intensity focused ultrasound ablation combined with transcatheter arterial chemoembolization improves long-term efficacy and prognosis of primary liver cancer

Internet

Similar Items